Nuvation Bio Inc. (NUVB:NYSE) closed at $4.57 on October 23, 2026, down 2.77% on the day. The stock trades 53.1% below its 52-week high of $9.75 and 16.6% above its 52-week low of $3.92. Over the past year, it lost 5.8%. Nuvation Bio Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, NUVB closed higher on 123 days (49%). Its best day was November 19, 2025 (+48.96%) and its worst was March 3, 2026 (-25.34%). The stock moved 10% or more in a single session 6 times. It opened at least 5% above the previous day's high 1 time.
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.
Find more stocks like NUVB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.